Index by author

August 01, 2021; Volume 48,Issue 8

  1. Al Awqati, Mina Z.

    1. Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-γ Antibody
      Mina Z. Al Awqati, Jason C. Sluzevich and Florentina Berianu
      The Journal of Rheumatology August 1 2021, 48 (8) 1340; DOI: https://doi.org/10.3899/jrheum.200399

  2. Aljaberi, Najla

    1. Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients
      Najla Aljaberi, Enas Ghulam, Emily A. Smitherman, Leslie Favier, Dana M.H. Dykes, Lara A. Danziger-Isakov, Rebecca C. Brady and Jennifer Huggins
      The Journal of Rheumatology August 1 2021, 48 (8) 1314-1321; DOI: https://doi.org/10.3899/jrheum.200283

  3. Allanore, Yannick

    1. Rapidly Progressive Systemic Sclerosis–associated Interstitial Lung Disease After Intravesical Bacillus Calmette-Guérin Therapy for Early-stage Bladder Cancer
      Gonçalo Boleto, Jérôme Avouac and Yannick Allanore
      The Journal of Rheumatology August 1 2021, 48 (8) 1348-1349; DOI: https://doi.org/10.3899/jrheum.201625

  4. Alten, Rieke

    1. Open Access
      Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
      Arthur Kavanaugh, Rene R. Westhovens, Kevin L. Winthrop, Susan J. Lee, YingMeei Tan, Di An, Lei Ye, John S. Sundy, Robin Besuyen, Luc Meuleners, Mykola Stanislavchuk, Alberto J. Spindler, Maria Greenwald, Rieke Alten and Mark C. Genovese
      The Journal of Rheumatology August 1 2021, 48 (8) 1230-1238; DOI: https://doi.org/10.3899/jrheum.201183

  5. An, Di

    1. Open Access
      Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
      Arthur Kavanaugh, Rene R. Westhovens, Kevin L. Winthrop, Susan J. Lee, YingMeei Tan, Di An, Lei Ye, John S. Sundy, Robin Besuyen, Luc Meuleners, Mykola Stanislavchuk, Alberto J. Spindler, Maria Greenwald, Rieke Alten and Mark C. Genovese
      The Journal of Rheumatology August 1 2021, 48 (8) 1230-1238; DOI: https://doi.org/10.3899/jrheum.201183

  6. Arkema, Elizabeth V.

    1. Open Access
      Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
      Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling and Eva Baecklund
      The Journal of Rheumatology August 1 2021, 48 (8) 1243-1250; DOI: https://doi.org/10.3899/jrheum.201251

  7. Askling, Johan

    1. Open Access
      Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
      Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling and Eva Baecklund
      The Journal of Rheumatology August 1 2021, 48 (8) 1243-1250; DOI: https://doi.org/10.3899/jrheum.201251

  8. Avouac, Jérôme

    1. Rapidly Progressive Systemic Sclerosis–associated Interstitial Lung Disease After Intravesical Bacillus Calmette-Guérin Therapy for Early-stage Bladder Cancer
      Gonçalo Boleto, Jérôme Avouac and Yannick Allanore
      The Journal of Rheumatology August 1 2021, 48 (8) 1348-1349; DOI: https://doi.org/10.3899/jrheum.201625

  9. Aydin, Sibel Zehra

    1. Open Access
      Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs
      Gurjit S. Kaeley, Lihi Eder, Sibel Zehra Aydin, Phoebe Rich and Catherine J. Bakewell
      The Journal of Rheumatology August 1 2021, 48 (8) 1208-1220; DOI: https://doi.org/10.3899/jrheum.201471

  10. Baecklund, Eva

    1. Open Access
      Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics
      Johanna Karlsson Sundbaum, Elizabeth V. Arkema, Judith Bruchfeld, Jerker Jonsson, Johan Askling and Eva Baecklund
      The Journal of Rheumatology August 1 2021, 48 (8) 1243-1250; DOI: https://doi.org/10.3899/jrheum.201251
« Previous (Pages : 1 2 3 4 5 6 ... 17) Next »
Back to top

In this issue